UBS Group’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
NAMI
JIC
OAM
PA
CCA
UBS Group's AORT Position: Q2 2026 in Review
UBS Group increased its Artivion (AORT) stake by 77% in Q2 2026, buying an estimated $5.52M and bringing the position to 454,401 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3422.
UBS Group first reported a position in AORT in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.8M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.
- UBS Group held 454,401 shares of Artivion worth $10.2M as of Q2 2026.
- UBS Group bought 197,479 Artivion shares in Q2 2026, an estimated $5.52M.
- Artivion made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3422 holding.
- UBS Group first reported a position in Artivion in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Artivion position peaked at $12.8M in Q4 2025.
- 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.